Evidence map›Paper›PMID 25884639›Full record

ArticleBMC public health2015

Antiretroviral treatment coverage in a rural district in Tanzania--a modeling study using empirical data.

Francis Levira, Abela Mpobela Agnarson, Honorati Masanja, Basia Zaba, Anna Mia Ekström, Anna Thorson

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Francis LeviraData Analysis Cluster, Ifakara Health Institute, Plot 463, Kiko Avenue, Mikocheni, P O Box 78378, Dar es salaam, Tanzania. flevira@ihi.or.tz.
Abela Mpobela AgnarsonDepartment of Public Health Sciences/Global Health (IHCAR), Karolinska Institutet, Stockholm, Sweden. abela@lucme.se.
Honorati MasanjaData Analysis Cluster, Ifakara Health Institute, Plot 463, Kiko Avenue, Mikocheni, P O Box 78378, Dar es salaam, Tanzania. hmasanja@ihi.or.tz.
Basia ZabaDepartment of Population Health, London School of Hygiene and Tropical Medicine, London, UK. basia.Zaba@lshtm.ac.uk.
Anna Mia EkströmDepartment of Public Health Sciences/Global Health (IHCAR), Karolinska Institutet, Stockholm, Sweden. anna.mia.ekstrom@ki.se.
Anna ThorsonDepartment of Public Health Sciences/Global Health (IHCAR), Karolinska Institutet, Stockholm, Sweden. anna.thorson@ki.se.
Ifakara Health Institute · TZKarolinska Institutet · SEKarolinska University Hospital · SELondon School of Hygiene & Tropical Medicine · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Tanzanian Government started scaling up its antiretroviral treatment (ART) program from referral, regional and district hospitals to primary health care facilities in October 2004. In 2010, most ART clinics were decentralized to primary health facilities. ART coverage, i.e. people living with HIV (PLHIV) on combination treatment as a proportion of those in need of treatment, provides the basis for evaluating the efficiency of ART programs at national and district level. We aimed to evaluate adult ART and pre-ART care coverage by age and sex at CD4 < 200, < 350 and all PLHIV in the Rufiji district of Tanzania from 2006 to 2010.

methodsThe numbers of people on ART and pre-ART care were obtained from routinely aggregated, patient-level, cohort data from care and treatment centers in the district. We used ALPHA model to predict the number in need of pre-ART care and ART by age and sex at CD4 < 200 and < 350.

resultsAdult ART coverage among PLHIV increased from 2.9% in 2006 to 17.6% in 2010. In 2010, coverage was 20% for women and 14.8% for men. ART coverage was 30.2% and 38.7% in 2010 with reference to CD4 criteria of 350 and 200 respectively. In 2010, ART coverage was 0 and 3.4% among young people aged 15-19 and 20-24 respectively. ART coverage among females aged 35-39 and 40-44 was 30.6 and 35% respectively in 2010. Adult pre-ART care coverage for PLHIV of CD4 < 350 increased from 5% in 2006 to 37.7% in 2010. The age-sex coverage patterns for pre-ART care were similar to ART coverage for both CD4 of 200 and 350 over the study period.

conclusionsART coverage in the Rufiji district is unevenly distributed and far from the universal coverage target of 80%, in particular among young men. The findings in 2010 are close to the most recent estimates of ART coverage in 2013. To strive for universal coverage, both the recruitment of new eligible individuals to pre-ART and ART and the successful retention of those already on ART in the program need to be prioritized.

Indexed as

Health Services AccessibilityRural PopulationAdolescentAdultAnti-Retroviral AgentsDatabases, FactualEmpirical ResearchFemaleHealth FacilitiesHIV InfectionsHumansMaleMiddle AgedPoliticsTanzaniaYoung AdultAnti-Retroviral Agents

Identifiers

PMID25884639
PMCPMC4349316
OpenAlexW2165411578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.